UPMC Hillman Cancer Center - Investigational Drug Service

Pittsburgh, Pennsylvania 15232

We've found

3 trials

at this facility

A Study Of Oral PF-02341066, A C-Met/Hepatocyte Growth Factor Tyrosine Kinase Inhibitor, In Patients With Advanced Cancer

Status: Enrolling, Phase I
Updated: 12/31/1969

from

Pittsburgh, PA

Javelin BRCA/ATM: Avelumab Plus Talazoparib in Patients With BRCA or ATM Mutant Solid Tumors

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Pittsburgh, PA

A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors

Status: Enrolling, Phase II
Updated: 12/31/1969

from

Pittsburgh, PA

Use our guide to learn which trials are right for you!